Mylan NV (NASDAQ:MYL)

26.85
Delayed Data
As of Apr 18
 +0.12 / +0.45%
Today’s Change
26.00
Today|||52-Week Range
42.50
-2.01%
Year-to-Date

Today’s Trading

Previous close26.73
Today’s open26.83
Day’s range26.57 - 27.18
Volume3,806,669
Average volume (3 months)5,252,793
Market cap--
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)-46.92%
Earnings growth (this year)-3.61%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.02%
P/E ratio39.5
Price/Sales1.24
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+0.81+0.98%
INCYIncyte Corp-0.36-0.48%
SGENSeattle Genetics Inc-1.62-2.29%
IONSIonis Pharmaceutical...+0.32+0.44%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 8, 2019
EPS forecast (this quarter)$0.85
Annual revenue (last year)$11.4B
Annual profit (last year)$352.5M
Net profit margin3.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts